Sep 27, 2022 / 08:30PM GMT
Operator
Good afternoon, everyone, and welcome to Aytu BioPharma's Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. (Operator Instructions) It's now my pleasure to turn the floor over to your host, Robert Blum with Lytham Partners. Sir, the floor is yours.
Robert A. Blum - Lytham Partners, LLC - Managing Partner
All right. Thank you very much. Good afternoon, everyone. And as the operator said, thank you for joining us for today's Aytu BioPharma Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. Joining us on today's call is Aytu's CEO, Josh Disbrow; and the company's Chief Financial Officer, Mark Oki. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.
I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the earnings press release issued earlier today.
Finally, I'd also like to call to your attention the customary safe harbor disclosure
Q4 2022 Aytu Biopharma Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot